Back to top
more

Xencor (XNCR)

(Delayed Data from NSDQ)

$18.37 USD

18.37
481,161

+0.12 (0.66%)

Updated Apr 23, 2024 04:00 PM ET

After-Market: $18.37 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (93 out of 252)

Industry: Medical - Drugs

Better trading starts here.

Balance Sheet

Research for XNCR

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Xencor, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 594 623 334 603 530
Receivables 11 29 66 11 22
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 18 23 24 23 7
Total Current Assets 623 675 424 638 558
Net Property & Equipment 66 59 28 22 16
Investments & Advances 210 58 332 17 72
Other Non-Current Assets 0 0 5 0 0
Deferred Charges 0 0 0 0 0
Intangibles 19 19 16 16 14
Deposits & Other Assets 1 1 1 0 0
Total Assets 953 846 838 703 670
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 14 10 14 9 10
Current Portion Long-Term Debt 6 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 24 19 19 18 9
Income Taxes Payable 6 0 0 0 0
Other Current Liabilities 32 30 37 93 45
Total Current Liabilities 85 64 71 121 67
Mortgages 0 0 0 0 0
Deferred Taxes/Income 125 0 0 0 2
Convertible Debt 0 0 0 0 0
Long-Term Debt 15 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 284 119 105 131 77
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 1 1 1 1
Capital Surplus 1,131 1,072 1,018 938 888
Retained Earnings -464 -338 -283 -366 -296
Other Equity 2 -7 -2 0 1
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 669 728 734 572 593
Total Liabilities & Shareholder's Equity 953 846 838 703 670
Total Common Equity 669 728 734 572 593
Shares Outstanding 60.80 59.90 58.40 57.40 56.70
Book Value Per Share 11.01 12.15 12.56 9.97 10.46

Fiscal Year End for Xencor, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 594 495 551 588
Receivables NA 11 55 20 20
Notes Receivable NA 0 0 0 0
Inventories NA 0 0 0 0
Other Current Assets NA 18 22 22 22
Total Current Assets NA 623 571 594 630
Net Property & Equipment NA 66 68 68 67
Investments & Advances NA 210 85 64 54
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 19 19 19 18
Deposits & Other Assets NA 1 1 1 1
Total Assets NA 953 778 778 803
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 14 15 14 15
Current Portion Long-Term Debt NA 6 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 24 24 18 15
Income Taxes Payable NA 6 0 0 0
Other Current Liabilities NA 32 9 8 30
Total Current Liabilities NA 85 53 45 65
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 125 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 15 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 0 0 0
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 284 109 99 120
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 1 1
Capital Surplus NA 1,131 1,114 1,101 1,086
Retained Earnings NA -464 -445 -421 -399
Other Equity NA 2 -1 -2 -4
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 669 669 679 684
Total Liabilities & Shareholder's Equity NA 953 778 778 803
Total Common Equity 0 669 669 679 684
Shares Outstanding 61.10 60.80 60.60 60.60 60.30
Book Value Per Share 0.00 11.01 11.04 11.20 11.34